TC
Tejara Capital Portfolio holdings
AUM
$216M
This Quarter Return
+7.71%
1 Year Return
-14.3%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$239M
AUM Growth
+$239M
(+36%)
Cap. Flow
+$52.1M
Cap. Flow
% of AUM
21.8%
Top 10 Holdings %
Top 10 Hldgs %
47.13%
Holding
79
New
15
Increased
27
Reduced
17
Closed
11
Top Buys
| 1 |
Roivant Sciences
ROIV
|
$19.9M |
| 2 |
Newmont
NEM
|
$9.57M |
| 3 |
Liberty Global Class A
LBTYA
|
$9.41M |
| 4 |
Nabors Industries
NBR
|
$6.45M |
| 5 |
Heron Therapeutics
HRTX
|
$5.38M |
Top Sells
| 1 |
Citigroup
C
|
$15.6M |
| 2 |
Cameco
CCJ
|
$7.57M |
| 3 |
Peabody Energy
BTU
|
$4.84M |
| 4 |
Collegium Pharmaceutical
COLL
|
$4.58M |
| 5 |
CNR
Core Natural Resources, Inc.
CNR
|
$3.31M |
Sector Composition
| 1 | Healthcare | 38.1% |
| 2 | Energy | 31.79% |
| 3 | Materials | 9.47% |
| 4 | Financials | 6.54% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Roivant Sciences
ROIV
$8.15B
| $24M | 10.04% | 2,134,895 +1,776,323 | +495% | +$19.9M |
|
2
Golar LNG
GLNG
$4.48B
| $11.7M | 4.89% | 508,280 | – | – |
|
3
Teva Pharmaceuticals
TEVA
$21.1B
| $11M | 4.62% | 1,056,006 +233,511 | +28% | +$2.44M |
|
|
4
Nabors Industries
NBR
$543M
| $10.9M | 4.54% | 132,925 +79,024 | +147% | +$6.45M |
|
|
5
Newmont
NEM
$81.7B
| $9.57M | 4.01% | +231,300 | New | +$9.57M |
|
|
6
Liberty Global Class A
LBTYA
$4B
| $9.41M | 3.94% | +529,500 | New | +$9.41M |
|
|
BORR
7
Borr Drilling
BORR
$833M
| $9.28M | 3.89% | 1,261,193 +41,888 | +3% | +$308K |
|
8
Scorpio Tankers
STNG
$2.57B
| $9.16M | 3.84% | 150,721 +83,600 | +125% | +$5.08M |
|
|
9
Heron Therapeutics
HRTX
$207M
| $8.97M | 3.76% | 5,275,236 +3,165,555 | +150% | +$5.38M |
|
|
MREO
10
Mereo BioPharma
MREO
$272M
| $8.58M | 3.59% | 3,713,129 +498,128 | +15% | +$1.15M |
|
11
NOV
NOV
$4.94B
| $8.13M | 3.41% | 401,065 +60,000 | +18% | +$1.22M |
|
|
12
Citigroup
C
$178B
| $7.9M | 3.31% | 153,621 -302,690 | -66% | -$15.6M |
|
13
Viatris
VTRS
$12.3B
| $6.64M | 2.78% | 612,815 +146,100 | +31% | +$1.58M |
|
14
The GEO Group
GEO
$2.94B
| $6.1M | 2.56% | 563,244 +155,000 | +38% | +$1.68M |
|
15
BGC Group
BGC
$4.65B
| $5.89M | 2.47% | 816,072 -102,740 | -11% | -$742K |
|
16
Orthofix Medical
OFIX
$592M
| $5.31M | 2.23% | 394,095 +184,300 | +88% | +$2.48M |
|
17
Freeport-McMoran
FCX
$63.7B
| $5.18M | 2.17% | +121,700 | New | +$5.18M |
|
18
Rekor Systems
REKR
$141M
| $4.85M | 2.03% | 1,456,589 +711,008 | +95% | +$2.37M |
|
19
scPharmaceuticals
SCPH
$295M
| $4.75M | 1.99% | 757,771 +656,357 | +647% | +$4.12M |
|
20
Forum Energy Technologies
FET
$315M
| $4.64M | 1.94% | 209,090 | – | – |
|
|
21
Collegium Pharmaceutical
COLL
$1.22B
| $4.34M | 1.82% | 141,099 -148,704 | -51% | -$4.58M |
|
22
Transocean
RIG
$2.86B
| $3.91M | 1.64% | +615,000 | New | +$3.91M |
|
23
Noble Corp
NE
$4.58B
| $3.87M | 1.62% | 80,445 +58,445 | +266% | +$2.81M |
|
|
24
Peabody Energy
BTU
$2.12B
| $3.68M | 1.54% | 151,267 -199,023 | -57% | -$4.84M |
|
25
Arcutis Biotherapeutics
ARQT
$1.86B
| $3.59M | 1.5% | 1,112,217 +803,038 | +260% | +$2.59M |
|